Clinical trial
Trial of VLTS-589 in Subjects With Intermittent Claudication
NCT00068133 · Valentis, Industry · Completed
Key facts
| NCT number | NCT00068133 |
|---|---|
| Title | Trial of VLTS-589 in Subjects With Intermittent Claudication |
| Official title | A Phase II Multicenter, Double-Blind, Placebo-Controlled, Trial of VLTS-589 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease |
| Lead sponsor | Valentis, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Intermittent Claudication, Peripheral Vascular Disease |
| Intervention type | Genetic |
| Interventions | Plasmid based Gene Transfer product-VLTS-589 |
| Enrollment | 100 |
| Start date | Jun 1, 2003 |
| Completion | Jun 1, 2005 |
| First posted | Sep 10, 2003 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: